The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the EU/EEA is essential for detecting emerging and increasing antimicrobial resistance. Since 2009, this surveillance has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC).
The European Centre for Disease Prevention and Control (ECDC) has published a report today highlighting the threat of increasing antimicrobial resistance (AMR) in Neisseria gonorrhoeae.
In July 2022, the European Commission adopted the proposal for a Regulation on standards of quality and safety for substances of human origin (SoHO) intended for human application.
ECDC, WHO and the German Federal Centre for Health Education (BZgA) have jointly developed public health advice for UEFA EURO 2024 to promote the safety and well-being of spectators attending matches.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 June 2024 and includes updates on SARS-CoV-2 variant classification, cholera, out-of-season increase in norovirus, seasonal surveillance on West Nile virus infections, Middle East respiratory syndrome coronavirus (MERS-CoV), influenza A(H5N2), Oropouche virus disease, and an overview of respiratory virus epidemiology in the EU/EEA.
Since the beginning of 2024, and as of 3 June 2024, four MERS cases, including two fatalities, have been reported in Saudi Arabia with date of onset in 2024.
The ECDC updates are based on available data reported through the European Surveillance System (TESSy) by the national public health authorities of EU/EEA countries.